ANAVEX 2-73/donepezil - Anavex Life Sciences Corporation
Alternative Names: ANAVEX 2-73/DPZ; ANAVEX PLUS; Donepezil/ANAVEX 2-73Latest Information Update: 27 Mar 2023
At a glance
- Originator Anavex Life Sciences
- Class Antidementias; Dimethylamines; Furans; Indans; Neuroprotectants; Nootropics; Piperidines; Small molecules
- Mechanism of Action Acetylcholinesterase inhibitors; Calcium channel antagonists; Muscarinic M2 receptor antagonists; Muscarinic M3 receptor antagonists; NMDA receptor antagonists; Sigma-1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Alzheimer's disease